KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Investment Income: 2009-2010

Historic Investment Income for Biomarin Pharmaceutical (BMRN) over the last 1 years, with Mar 2010 value amounting to -$3,000.

  • Biomarin Pharmaceutical's Investment Income was N/A to -$3,000 in Q1 2010 from the same period last year, while for Dec 2009 it was $2,000, marking a year-over-year change of. This contributed to the annual value of $5,000 for FY2009, which is N/A change from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Investment Income stood at -$3,000 for Q1 2010, which was up 99.95% from -$6.0 million recorded in Q4 2009.
  • Over the past 5 years, Biomarin Pharmaceutical's Investment Income peaked at $6.0 million during Q3 2009, and registered a low of -$6.0 million during Q4 2009.
  • Its 2-year average for Investment Income is $0, with a median of -$500 in 2009.